← FDA Drug Approvals (Drugs@FDA)

SUMATRIPTAN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2021-02-22

Drug application

FDA Application #

ANDA214209

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUMATRIPTAN

Generic name

SUMATRIPTAN

Active ingredients

SUMATRIPTAN

Dosage form

SPRAY

Route

NASAL

Marketing status

Prescription

Sponsor

CIPLA

Manufacturer

Cipla USA Inc.

First approval

2021-02-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown